AVI BioPharma, Inc (AVII) Names Dr. Leslie Hudson as Chief Executive Officer
AVI BioPharma, Inc. (AVII) announced that the company's board of directors has elected Leslie Hudson, Ph.D. to serve as their chief executive officer, effective immediately. Dr. Hudson will bring more than 20 years of leadership experience in the pharmaceutical industry to this new position. Previously, Dr. Hudson served as the interim president and CEO of Nabi Biopharmaceuticals. Here, Dr. Hudson was responsible for the reorganization and turnaround of the company. Dr. Hudson also served as the CEO and president of DOV Pharmaceutical Inc., a publicly traded biopharmaceutical company, and also held several senior positions at Pharmacia Corporation, Dr. Hudson received…